{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T05:47:54Z","timestamp":1750916874023},"reference-count":16,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2024,5,1]]},"DOI":"10.1248\/bpb.b23-00767","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T22:17:30Z","timestamp":1714515450000},"page":"924-929","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Human Mobility Flow in the Region-to-Region Spread of Respiratory Syncytial Virus Infection among Infants: An Infographic Analysis"],"prefix":"10.1248","volume":"47","author":[{"given":"Hide","family":"Sasaki","sequence":"first","affiliation":[{"name":"Department of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Seoka","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Komano","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Walsh EE, Englund JA. Respiratory Syncytial Virus. <i>Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases 9th Ed<\/i>. (Benette JE, <i>et al.<\/i>, ed.) ELSEVIER, Philadelphia, pp. 2093\u20132103 (2020)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kulkarni H, Smith CM, Lee DDH, Hirst RA, Easton AJ, O\u2019Callaghan C. Evidence of respiratory syncytial virus spread by aerosol: time to revisit infection control strategies? <i>Am. J. Respir. Crit. Care Med.<\/i>, <b>194<\/b>, 308\u2013316 (2016).","DOI":"10.1164\/rccm.201509-1833OC"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kobayashi Y, Togo K, Agosti Y, McLaughlin JM. Epidemiology of respiratory syncytial virus in Japan: a nationwide claims database analysis. <i>Pediatr. Int.<\/i>, <b>64<\/b>, e14957 (2022).","DOI":"10.1111\/ped.14957"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Watanabe T, Yabu T. Japan\u2019s voluntary lockdown. <i>PLOS ONE<\/i>, <b>16<\/b>, e0252468 (2021).","DOI":"10.1371\/journal.pone.0252468"},{"key":"5","unstructured":"5) Japan National Tourism Organization (JNTO). \u201cJapan Tourism Statistics.\u201d: \u2039https:\/\/statistics.jnto.go.jp\u203a, accessed 29 October, 2023."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sakon N, Takahashi T, Yoshida T, Shirai T, Komano J. Impact of COVID-19 countermeasures on pediatric infections. <i>Microorganisms<\/i>, <b>10<\/b>, 1947 (2022).","DOI":"10.3390\/microorganisms10101947"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nomura S, Tanoue Y, Yoneoka D, Gilmour S, Kawashima T, Eguchi A, Miyata H. Mobility patterns in different age groups in Japan during the COVID-19 pandemic: a small area time series analysis through March 2021. <i>J. Urban Health<\/i>, <b>98<\/b>, 635\u2013641 (2021).","DOI":"10.1007\/s11524-021-00566-7"},{"key":"8","unstructured":"8) Regional Economy Society Analyzing System (RESAS), Cabinet Office, Government of Japan. \u201cV-RESAS.\u201d: \u2039https:\/\/v-resas.go.jp\u203a, accessed 29 October, 2023."},{"key":"9","unstructured":"9) Infectious Diseases Weekly Report (IDWR). \u201cIDWR Surveillance Data Table.\u201d: \u2039https:\/\/www.niid.go.jp\/niid\/en\/survaillance-data-table-english.html\u203a, accessed 29 October, 2023."},{"key":"10","unstructured":"10) Organization for Economic Co-operation and Development (OECD). \u201cHealth for the People, by the People.\u201d: \u2039https:\/\/www.oecd.org\/health\/health-for-the-people-by-the-people-c259e79a-en.htm\u203a, accessed 29 October, 2023."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Prather KA, Marr LC, Schooley RT, McDiarmid MA, Wilson ME, Milton DK. Airborne transmission of SARS-CoV-2. <i>Science<\/i>, <b>370<\/b>, 303\u2013304 (2020).","DOI":"10.1126\/science.abf0521"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ. Identifying airborne transmission as the dominant route for the spread of COVID-19. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>117<\/b>, 14857\u201314863 (2020).","DOI":"10.1073\/pnas.2009637117"},{"key":"13","unstructured":"13) Rabaan AA, Al-Ahmed SH, Al-Malkey M, <i>et al.<\/i> Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols. <i>Infez. Med.<\/i>, <b>29<\/b>, 10\u201319 (2021)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Syangtan G, Bista S, Dawadi P, Rayamajhee B, Shrestha LB, Tuladhar R, Joshi DR. Asymptomatic SARS-CoV-2 carriers: a systematic review and meta-analysis. <i>Front. Public Health<\/i>, <b>8<\/b>, 587374 (2021).","DOI":"10.3389\/fpubh.2020.587374"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT, Slayton RB, Biggerstaff M, Butler JC. SARS-CoV-2 transmission from people without COVID-19 symptoms. <i>JAMA Netw. Open<\/i>, <b>4<\/b>, e2035057 (2021).","DOI":"10.1001\/jamanetworkopen.2020.35057"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Furukawa NW, Brooks JT, Sobel J. Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic. <i>Emerg. Infect. Dis.<\/i>, <b>26<\/b> (2020).","DOI":"10.3201\/eid2607.201595"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/5\/47_b23-00767\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T03:25:25Z","timestamp":1714793125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/5\/47_b23-00767\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b23-00767","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"article-number":"b23-00767"}}